Saturday, July 12, 2025

"COVID-19 Impact on Seasonal Outbreak Detection: SARIMAX-LSTM Hybrid Model Explained #InfectiousDiseases #COVID19Research #Pencis"



INTRODUCTION

Seasonal infectious diseases have long posed significant public health challenges in the Republic of Korea. Influenza, norovirus, severe fever with thrombocytopenia syndrome (SFTS), and tsutsugamushi disease each follow distinct epidemiological patterns influenced by seasonal and environmental factors. However, the COVID-19 pandemic has introduced a profound disruption to global disease transmission dynamics. This study seeks to quantify the long-term patterns of these infections between 2005 and 2023, while analyzing how COVID-19 impacted their seasonality and outbreak intensity. By integrating classical time-series forecasting through the SARIMAX model with advanced deep learning via LSTM networks, and combining them in a hybrid SARIMAX-LSTM model, this research delivers robust predictive insights. Meteorological data and change point detection were employed to enhance the understanding of outbreak shifts. The goal is not only to understand historical trends but also to forecast and prepare for future outbreaks, particularly in a post-pandemic era.

EPIDEMIOLOGICAL TRENDS ACROSS TWO DECADES

The study spans 18 years, offering a comprehensive view of infectious disease seasonality in South Korea. Influenza and norovirus displayed predictable annual patterns until 2020, while SFTS and tsutsugamushi disease showed more static endemic behaviors. The onset of COVID-19 disrupted these trends, significantly reducing the incidence of influenza-like illnesses and norovirus infections. Interestingly, vector-borne diseases such as SFTS and tsutsugamushi disease did not follow this decline, suggesting that their transmission mechanisms were less impacted by pandemic-related public health interventions such as mask-wearing and social distancing. This divergence reinforces the need to categorize infectious diseases based on both their transmission modes and vulnerability to behavioral changes within the population.

IMPACT OF COVID-19 ON SEASONAL DISEASES

The global pandemic triggered a cascade of health policy shifts that influenced not only SARS-CoV-2 but also other respiratory and gastrointestinal diseases. The study reveals that the incidence of influenza sharply declined during the pandemic and has not returned to pre-pandemic levels even in recent years. Norovirus followed a different trajectory—while it dropped in 2020, it rebounded to prior levels soon after. This suggests that viral shedding and environmental persistence may play crucial roles in post-pandemic resurgence. On the other hand, the relatively stable patterns of SFTS and tsutsugamushi disease throughout the pandemic period imply limited impact from urban-centric COVID-19 interventions, further underlining the importance of ecological and vector-focused disease modeling.

ADVANCED MODELING TECHNIQUES FOR OUTBREAK DETECTION

In this study, SARIMAX, LSTM, and a novel SARIMAX-LSTM hybrid model were implemented to predict infectious disease trends. The SARIMAX model leverages temporal patterns and incorporates exogenous variables such as meteorological data. Meanwhile, LSTM neural networks process long-term dependencies in sequential data. Combining these methodologies produced a hybrid model that demonstrated superior performance in outbreak forecasting. This approach enabled the identification of subtle trend shifts and seasonal fluctuations across diseases. The application of change point detection (CPD) techniques further strengthened the models by highlighting statistically significant deviations in disease incidence, especially during the COVID-19 outbreak period. These insights are essential for early warning systems and targeted resource allocation.

DIFFERENTIAL RECOVERY AND RESURGENCE POTENTIAL

Post-COVID-19 disease dynamics have shown that not all infections recover at the same pace or pattern. Influenza, for instance, experienced a steep decline but remains suppressed compared to pre-pandemic baselines, hinting at altered immunity or sustained behavior changes. Conversely, norovirus quickly resumed its cyclical outbreaks. Predictive modeling suggests that influenza-like illness (ILI) outbreaks may resurge in the near future due to waning immunity and lowered population-level exposure. These findings stress the need to monitor evolving trends rather than assume automatic recovery of seasonal patterns. Disease-specific strategies—such as continued surveillance, targeted vaccination, and behavior-based interventions—must be developed in anticipation of these shifts.

PUBLIC HEALTH IMPLICATIONS AND STRATEGIC RECOMMENDATIONS

The differential effects of the COVID-19 pandemic on infectious disease incidence call for disease-specific public health responses. For respiratory and gastrointestinal viruses like influenza and norovirus, adaptive interventions—including enhanced surveillance during transition seasons and targeted public awareness campaigns—are critical. Vector-borne diseases, which remained stable throughout the pandemic, require sustained ecological monitoring and regional preparedness. Predictive analytics using hybrid SARIMAX-LSTM models and real-time meteorological data can serve as early warning systems. These tools empower healthcare agencies to preempt outbreaks, optimize resource allocation, and reduce the healthcare burden. Moving forward, preparedness must factor in both historical data and the new post-pandemic normal.


๐Ÿ‘‰ Visit: https://infectious-diseases-conferences.pencis.com
๐Ÿ“ฉ Contact: infectioussupport@pencis.com
๐Ÿ… Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee
๐Ÿ“ Register: https://infectious-diseases-conferences.pencis.com/award-registration/


HASHTAGS

#InfectiousDiseases, #SeasonalDiseases, #SARIMAXModel, #LSTMForecasting, #HybridModels, #OutbreakDetection, #COVID19Impact, #InfluenzaTrends, #NorovirusSurveillance, #SFTSAnalysis, #TsutsugamushiDisease, #ChangePointDetection, #PublicHealthResearch, #EpidemiologyKorea, #DeepLearningModels, #PandemicInfluence, #DiseasePrediction, #MeteorologicalData, #HealthSurveillance, #DataDrivenHealthPolicy,

Friday, July 11, 2025

Unveiling COVID-19's Lingering Effects: A Chinese Case–Control Study | #LongCovid #PencisResearch #PostCovidImpact

 



INTRODUCTION

The emergence of breakthrough SARS-CoV-2 infections during the Omicron wave has reignited the urgency to understand factors influencing infection risk and clinical progression. This study, conducted across six provinces in China, adopts a case–control design involving over 20,000 participants to identify predictors for the incidence, persistence, and severity of symptoms after COVID-19 infection. Through matching cases and controls on age, sex, and region, and analyzing a broad range of individual-level variables using multivariate logistic regression, the study provides a comprehensive exploration of host and behavioral determinants. Key findings reveal associations between lifestyle factors, such as tea and coffee consumption or alcohol intake, and infection risk or symptom severity. Notably, both underweight and overweight status emerged as significant predictors of poor outcomes. By incorporating real-world surveillance data and considering vaccination history, this research offers critical insight into COVID-19 symptom trajectories in a post-vaccine context. Its emphasis on individualized risk profiling offers a foundation for targeted public health interventions and long-term management of post-COVID complications in Chinese adults.

DEMOGRAPHIC AND LIFESTYLE DETERMINANTS OF INFECTION

Demographic and behavioral attributes play a crucial role in shaping the risk of breakthrough SARS-CoV-2 infections. In this study, individuals with occasional alcohol consumption, tea and coffee habits, or overweight status exhibited a higher probability of infection. Conversely, weekly alcohol intake and smoking appeared to reduce infection risk, challenging conventional assumptions and suggesting complex behavioral-health interactions. Female participants showed greater vulnerability to persistent and severe symptoms, potentially reflecting hormonal, immunological, or sociocultural factors. These associations emphasize the need to consider nuanced lifestyle profiles in risk communication and prevention efforts.

THE ROLE OF COMORBIDITIES IN COVID-19 SEVERITY

The presence of pre-existing medical conditions significantly influenced both the likelihood and outcomes of SARS-CoV-2 breakthrough infections. Comorbidities were not only linked with increased infection risk but also with a higher probability of developing prolonged or moderate-to-severe symptoms. This reinforces earlier findings that chronic diseases amplify COVID-19-related complications, even in the post-vaccination era. Furthermore, individuals with a history of immunotherapy also demonstrated greater susceptibility, underscoring the importance of tailored clinical management for immunocompromised populations.

NUTRITIONAL STATUS AND WEIGHT-RELATED RISKS

Nutritional and bodyweight indicators were strongly associated with both infection susceptibility and symptom severity. The study found that being underweight or overweight elevated the odds of developing severe or persistent symptoms post-infection. This reflects a dual burden wherein both nutritional insufficiency and metabolic overload may impair immune resilience. Public health recommendations should therefore promote balanced nutrition as a critical component of infection preparedness, particularly in the face of evolving SARS-CoV-2 variants.

VACCINATION TIMING AND INFECTION OUTCOMES

A longer duration since the last COVID-19 vaccination was linked with increased infection risk in the cohort studied. This temporal association highlights waning immunity as a key vulnerability in the population, especially during high-transmission phases like the Omicron wave. The data supports the strategic administration of booster doses, particularly for at-risk individuals, to maintain protective immunity. Integration of vaccination schedules with personalized risk assessments could optimize long-term health outcomes and mitigate future surges.

TOWARD PERSONALIZED COVID-19 MANAGEMENT STRATEGIES

The study’s multifactorial findings highlight the necessity for personalized prevention and management strategies for COVID-19. No single determinant was solely responsible for infection or symptom progression; rather, an interplay of lifestyle behaviors, demographic factors, and health conditions shaped the clinical course. Public health frameworks should integrate these variables to develop adaptive strategies that are sensitive to individual profiles. From vaccination timing to nutritional advice and comorbidity management, a personalized approach can better address the long-term impacts of COVID-19 on diverse populations.


Visit: https://infectious-diseases-conferences.pencis.com
Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee
Registration Page: https://infectious-diseases-conferences.pencis.com/award-registration/
Contact Us: infectioussupport@pencis.com


Hashtags:

#SARSCoV2, #COVID19Research, #BreakthroughInfections, #OmicronWave, #PublicHealth, #Epidemiology, #COVID19China, #CaseControlStudy, #SymptomPersistence, #SymptomSeverity, #VaccinationImpact, #LifestyleFactors, #Comorbidities, #RiskAssessment, #HealthDeterminants, #PersonalizedMedicine, #WeightAndCOVID, #BehavioralHealth, #COVIDPrevention, #EpidemicSurveillance

Thursday, July 10, 2025

Excellence in Innovation Award: Celebrating Breakthroughs in Infectious Diseases Research | #Pencis #InnovationAward

                                      

                                           

INTRODUCTION

The Excellence in Innovation Award by Pencis is a prestigious global recognition that applauds the relentless efforts and trailblazing achievements of researchers in the field of infectious diseases. Designed to honor those who have redefined healthcare practices, this award acknowledges professionals whose pioneering work has led to substantial breakthroughs in understanding, diagnosing, preventing, or treating infectious diseases. As the global burden of infectious diseases continues to challenge healthcare systems, this award underscores the importance of research-driven innovation to combat both emerging and re-emerging threats. Whether by unraveling the complexities of pathogens, formulating new vaccine strategies, or implementing transformative public health measures, awardees serve as catalysts for global health improvement. This accolade not only recognizes past accomplishments but also encourages continued excellence in biomedical research, spotlighting the individuals who transform ideas into life-saving impact. By celebrating these achievements, Pencis drives a broader vision for future-forward infectious disease research worldwide.

BREAKTHROUGHS IN MICROBIOLOGICAL RESEARCH

Microbiological research forms the bedrock of many advancements recognized by the Excellence in Innovation Award. From characterizing novel bacterial strains to decoding viral genomes, award recipients have revolutionized how pathogens are identified, monitored, and understood. These breakthroughs lay the groundwork for accurate diagnostics and targeted treatments. Advanced sequencing techniques, pathogen-host interaction models, and microbial resistance profiling have enabled researchers to make landmark discoveries. Their work has deepened our understanding of pathogen evolution and transmission, enabling earlier outbreak detection and more effective interventions.

INNOVATION IN VACCINE DEVELOPMENT

Vaccines remain one of the most powerful tools in infectious disease prevention. Innovators recognized by Pencis have introduced cutting-edge technologies, such as mRNA-based platforms, nanoparticle vaccines, and thermostable formulations, that have transformed vaccine science. These efforts are crucial in addressing pathogens with high mutation rates and limited existing prophylactic options. Research acknowledged by the award often involves cross-disciplinary collaboration and long-term impact, proving vital during global health crises such as COVID-19 and Ebola. The emphasis on equitable access and immunological precision makes this field particularly commendable.

ADVANCES IN ANTIMICROBIAL RESISTANCE STRATEGIES

The growing crisis of antimicrobial resistance (AMR) has been a major focus among award recipients. Their research offers innovative approaches to counter resistant strains, ranging from novel antibiotics and combination therapies to phage therapy and antimicrobial peptides. Additionally, breakthroughs in AMR surveillance technologies have allowed better tracking of resistance trends globally. The Excellence in Innovation Award honors such critical contributions, which are indispensable in extending the efficacy of current treatments and safeguarding future generations against superbugs.

PUBLIC HEALTH INTERVENTIONS AND EPIDEMIOLOGICAL IMPACT

Innovative public health research plays a central role in shaping disease control strategies. Awardees in this category have developed data-driven interventions, improved disease surveillance systems, and modeled effective outbreak responses. Their research often informs global and national policies, strengthening health system resilience. Whether it’s through implementing digital contact tracing tools or assessing vaccination coverage disparities, their findings bridge the gap between science and real-world application. These contributions are vital to preventing and mitigating the spread of infectious diseases at scale.

TRANSLATIONAL MEDICAL RESEARCH AND THERAPEUTIC DISCOVERY

The Excellence in Innovation Award also honors researchers who translate laboratory findings into clinical applications. These individuals pioneer therapeutic discoveries, including antiviral drugs, immune modulators, and biologics tailored to infectious diseases. Translational research not only accelerates drug development but also ensures relevance to patient care. Many recipients have led clinical trials that redefined treatment protocols and enhanced survival outcomes in infectious disease cases. Their work reflects the synergy between bench science and bedside application—critical for real-world medical transformation.


๐ŸŽฏ Visithttps://infectious-diseases-conferences.pencis.com
๐Ÿ“ Nominate Nowhttps://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee
๐Ÿงพ Registration Pagehttps://infectious-diseases-conferences.pencis.com/award-registration/
๐Ÿ“ฉ Contact Usinfectioussupport@pencis.com


Hashtags:

#InfectiousDiseases, #InnovationAward, #PencisResearch, #MicrobiologyBreakthrough, #VaccineDevelopment, #AMRResearch, #PublicHealth, #TherapeuticDiscovery, #TranslationalMedicine, #PathogenGenomics, #GlobalHealth, #Epidemiology, #ViralResearch, #AntimicrobialResistance, #ScientificExcellence, #BiomedicalResearch, #HealthInnovation, #DiseasePrevention, #MedicalInnovation, #FutureOfMedicine,

Wednesday, July 9, 2025

Ultrasound-Guided Parasternal Block in Off-Pump CABG: A Game-Changer in Cardiac Anesthesia | #Pencis



INTRODUCTION

Effective postoperative pain management is a cornerstone of recovery after cardiac surgery, particularly in off-pump coronary artery bypass (OPCAB) procedures where median sternotomy often results in significant sternal pain. This discomfort can delay recovery, extend ICU stays, and may lead to chronic postoperative sternal pain syndrome. The implementation of ultrasound-guided regional blocks has gained traction as part of Enhanced Recovery After Cardiac Surgery (ERACS) protocols. Among these, the parasternal intercostal plane block (PIPB) has shown promise in mitigating postoperative pain. This single-center retrospective cohort study evaluates the clinical efficacy of a deep, single-shot PIPB in managing acute postoperative pain among 157 OPCAB patients. By comparing those who received the block (38 patients) to a standard therapy group (119 patients), and applying propensity score matching, the study provides insight into pain outcomes, analgesic usage, extubation times, and ICU metrics. The findings offer critical evidence for incorporating PIPB into multimodal analgesic strategies.

ANALGESIC OUTCOMES AND OPIOID SPARING EFFECTS

One of the central objectives of the study was to evaluate whether deep parasternal intercostal plane blocks (PIPB) could reduce the need for opioid analgesics. Patients who received PIPB demonstrated a significantly lower requirement for piritramide at both 24 and 48 hours postoperatively. Furthermore, the total morphine equivalent (ME) requirement was considerably reduced in the PIPB group. These opioid-sparing effects are clinically relevant, particularly in light of ongoing concerns about opioid overuse and associated complications. The results confirm the potential of PIPB as a non-opioid alternative that can enhance patient safety and reduce pharmacological burden during the early recovery phase.

EVALUATION OF PAIN PERCEPTION THROUGH BPS AND NRS SCORES

Accurate assessment of patient pain perception was integral to this study’s methodology. Behavioral Pain Scores (BPS) and Numeric Rating Scores (NRS) were used to measure postoperative pain levels up to 48 hours after extubation. Results indicated that patients who received the deep PIPB reported significantly lower NRS values. These subjective pain scores further validated the block’s analgesic effectiveness. Although BPS scores were not explicitly detailed in the summary, the overall trend suggested that patients had improved comfort, leading to faster recovery and reduced reliance on emergency analgesia. This highlights the relevance of integrating both objective and subjective tools in postoperative pain evaluation.

TIME TO EXTUBATION AND EARLY RECOVERY METRICS

An encouraging finding of the study was the reduction in time to extubation among patients who underwent the PIPB procedure. Faster extubation is a critical parameter within ERACS protocols and often correlates with better pain control and overall physiological stability. The PIPB group exhibited improved readiness for weaning from mechanical ventilation, likely due to reduced opioid-induced respiratory depression and enhanced analgesia. However, while extubation times were positively affected, the study did not find significant differences in ICU length of stay. This suggests that while PIPB influences immediate postoperative recovery, additional variables impact longer-term ICU outcomes.

PROPENSITY SCORE MATCHING FOR VALIDATION

To reinforce the reliability of the study findings, a one-to-one propensity score matching analysis was performed. This statistical technique minimizes selection bias by aligning patient characteristics between the PIPB and non-PIPB groups, ensuring that observed differences in outcomes are more likely due to the intervention rather than confounding factors. Post-matching analysis reaffirmed the primary results: patients in the PIPB group required fewer intravenous analgesics and experienced improved early recovery outcomes. This strengthens the internal validity of the study and supports the adoption of PIPB in standardized perioperative care protocols for cardiac surgery.

LIMITATIONS AND FUTURE RESEARCH DIRECTIONS

While the study presents robust evidence supporting deep PIPB in OPCAB surgeries, it is not without limitations. Being a retrospective, single-center analysis, it is subject to inherent biases despite propensity score matching. Moreover, some outcomes like ICU stay, incidence of nausea, and vomiting did not differ significantly, suggesting a need for larger, multicenter randomized controlled trials to further validate findings. Future research could also explore the benefits of continuous versus single-shot PIPB, long-term pain outcomes, and quality-of-life metrics to better understand the full impact of this technique in cardiac surgical care.


Visit: https://infectious-diseases-conferences.pencis.com
Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee
Register: https://infectious-diseases-conferences.pencis.com/award-registration/
Contact: infectioussupport@pencis.com


Hashtags

#UltrasoundGuidedBlock, #ParasternalBlock, #CardiacSurgeryPain, #OPCAB, #SternalPainRelief, #RegionalAnesthesia, #MultimodalAnalgesia, #PainManagement, #PIPB, #DeepParasternalBlock, #PostoperativeCare, #Anesthesiology, #CardiothoracicRecovery, #NRS, #BPS, #MorphineReduction, #ERACS, #AnalgesiaInnovation, #PropensityScoreMatching, #EnhancedRecovery,

Tuesday, July 8, 2025

Evolution of pks+ Klebsiella pneumoniae: Global Threats & Local Patterns | #Klebsiella #AMR #Pencis



INTRODUCTION

The emergence and persistence of pks-positive Klebsiella pneumoniae (pks⁺ KPN) have garnered significant attention due to their potent genotoxicity and elevated virulence potential. These strains harbor the pks genomic island responsible for the biosynthesis of colibactin, a genotoxin linked to DNA damage and colorectal cancer. Despite their clinical significance, comprehensive data on their epidemiology and evolution remain sparse. This study focuses on elucidating the molecular epidemiology and evolutionary patterns of pks⁺ KPN strains using extensive clinical isolate data and global genomic resources. By integrating multilocus sequence typing (MLST), virulence profiling, pan-genomics, and KEGG functional enrichment, the investigation aims to unveil the genetic architecture and biological functions that may drive the dominance and spread of these strains. The findings contribute critical insights into the development of precision-targeted surveillance and infection control strategies.

MOLECULAR EPIDEMIOLOGY OF pks⁺ KPN

An in-depth molecular epidemiological survey of 873 K. pneumoniae isolates revealed that 105 (12.03%) were pks⁺, predominantly obtained from infectious disease and surgical departments. Notably, these strains were more common in non-carbapenem-resistant isolates, suggesting a distinct evolutionary trajectory and clinical profile compared to drug-resistant variants. The disproportionately higher prevalence in non-CRKP isolates (25.45% vs. 1.04%, p < 0.001) indicates a trade-off between virulence and resistance, aligning with previous hypotheses that high-virulence KPN often lack carbapenem resistance. This epidemiological trend underpins the importance of routine pks island screening, particularly in departments managing younger and more vulnerable patient populations.

CLONAL STRUCTURE AND VIRULENCE TRAITS

pks⁺ K. pneumoniae isolates exhibited a remarkably conserved clonal structure, with ST23-KL1 representing 66.7% of the strains, contrasting with the genetic diversity seen in pks⁻ populations. Virulence gene profiling revealed significantly elevated rates of peg344, iucA, rmpA, rmpA2, and iroB in pks⁺ strains, corroborating their hypervirulent phenotype. Moreover, infections caused by these strains occurred in relatively younger patients, reinforcing the hypothesis that virulence traits may compensate for antibiotic susceptibility. These findings highlight the necessity of clonal and virulence gene surveillance in routine diagnostic protocols to better predict pathogenic potential.

GLOBAL DISTRIBUTION AND PHYLOGENETIC INSIGHTS

The analysis of 706 global pks⁺ KPN genomes demonstrated the predominance of ST23 (45.18%), ST11 (15.72%), and ST258 (15.16%) across diverse geographic regions. The phylogenetic construction revealed five distinct evolutionary clades, reflecting varied evolutionary pressures and transmission routes. The predominance of ST23 across both local and international datasets further supports its adaptation and survival advantage. The clustering of strains into defined phylogenetic clades offers a framework for understanding the evolutionary dynamics and helps trace epidemiological links across institutions and regions.

GENOMIC EVOLUTION AND FUNCTIONAL ENRICHMENT

Comparative core-genome analysis between dominant pks⁺ strains uncovered 245 lineage-specific genes, with 96 genes conserved among key clonal groups. KEGG pathway analysis indicated significant enrichment in galactose metabolism—a potentially crucial adaptation mechanism enhancing environmental survival, host colonization, and possibly metabolic crosstalk with the host microbiota. The genomic convergence around this metabolic pathway suggests evolutionary selection favoring specific metabolic capabilities in successful clones like ST23. These data highlight the importance of metabolic profiling in the context of virulence and fitness.

IMPLICATIONS FOR INFECTION CONTROL AND FUTURE RESEARCH

This study provides foundational evidence supporting the integration of genomic surveillance into hospital infection control programs. The delineation of pks⁺ KPN's clonal dissemination, virulence attributes, and metabolic enrichment opens avenues for targeted therapeutic and preventive measures. Strategies should prioritize early detection of hypervirulent clones and exploration of metabolic inhibitors as adjunct therapies. Future research should expand functional analyses of lineage-specific genes and their roles in host-pathogen interactions. Additionally, evaluating pks island expression and colibactin production in clinical contexts may yield deeper insights into their pathogenic role.


๐Ÿ”— Visit: https://infectious-diseases-conferences.pencis.com
๐Ÿ† Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee
๐Ÿ“ Register: https://infectious-diseases-conferences.pencis.com/award-registration/
๐Ÿ“ฉ Contact: infectioussupport@pencis.com


HASHTAGS

#KlebsiellaPneumoniae, #pksIsland, #HypervirulentKlebsiella, #ST23, #GenomicSurveillance, #MLST, #KEGGAnalysis, #GalactoseMetabolism, #VirulenceGenes, #AntibioticResistance, #CarbapenemSensitive, #ClinicalMicrobiology, #MolecularEpidemiology, #Colibactin, #PathogenEvolution, #BacterialGenomics, #HospitalInfections, #PublicHealthGenomics, #InfectionControl, #Pencis,

Monday, July 7, 2025

Microbial Food Safety & Antimicrobial Resistance: A Public Health Crisis | #pencis #FoodSafety #AMR


                                                             

INTRODUCTION ๐Ÿงฌ

Microbial food safety and antimicrobial resistance (AMR) are increasingly intertwined challenges threatening global public health, food systems, and sustainable development. The proliferation of resistant foodborne pathogens—such as Salmonella spp., Escherichia coli, Listeria monocytogenes, and Campylobacter spp.—reflects a crisis driven by interconnected human, animal, and environmental interactions. This convergence demands a unified One Health approach to research and response. The review highlights critical dimensions of AMR's development and transmission, emphasizing the impact of antibiotic misuse in agriculture, aquaculture, and healthcare. While scientific advancements like metagenomics and CRISPR-based interventions provide new tools, their global implementation remains uneven. Especially in low- and middle-income countries (LMICs), structural and economic barriers hinder widespread surveillance and treatment. Addressing this requires robust, science-informed policies, international cooperation, and inclusive education strategies to safeguard food safety and human health.

PATHOGENIC DYNAMICS IN THE FOOD CHAIN ๐Ÿฆ 

The food chain serves as a major conduit for antimicrobial-resistant pathogens, enabling resistance genes to spread from farms to forks. Bacteria such as E. coli and Salmonella spp. can acquire resistance through horizontal gene transfer and selective pressure induced by antibiotic overuse in animal husbandry. These pathogens persist through various stages of food production, including slaughter, processing, distribution, and consumption. Raw or undercooked food, poor sanitation, and improper handling exacerbate this risk. This section explores the molecular mechanisms of resistance development within foodborne microbes and their implications for public health. Studies focusing on the genetic mobility of resistance determinants via plasmids, integrons, and transposons are essential to understanding how AMR evolves in the food system. Integrated genomic research can illuminate potential intervention points to disrupt these transmission pathways and restore microbiological safety.

ONE HEALTH INTEGRATION FOR AMR MITIGATION ๐ŸŒ

The One Health approach bridges the interconnected health of humans, animals, and the environment, offering a holistic lens through which AMR in food safety can be addressed. Antibiotics used in veterinary medicine and animal agriculture can contribute to environmental contamination, creating resistance reservoirs in soil, water, and wastewater. Resistant bacteria or genes originating in livestock can migrate to human populations through direct contact, contaminated food, or environmental exposure. This section emphasizes the importance of intersectoral collaboration among microbiologists, veterinarians, ecologists, and policymakers. Research must continue to map the AMR ecosystem across sectors, facilitating surveillance and response at the interfaces where resistance emerges and circulates. One Health surveillance programs offer powerful insights, but their success hinges on policy coherence, data sharing, and cross-border scientific alliances.

ADVANCEMENTS IN DIAGNOSTICS AND GENOMIC TOOLS ๐Ÿ”ฌ

Modern research tools have revolutionized AMR detection and pathogen characterization in foodborne settings. Next-generation sequencing (NGS), metagenomic profiling, and CRISPR-based diagnostics provide unprecedented resolution in identifying resistance genes, virulence factors, and microbial signatures. These methods enable real-time monitoring of microbial populations and facilitate early outbreak detection, even before clinical manifestations occur. Moreover, they support the development of personalized food safety strategies and predictive AMR models. Despite these advances, implementation remains patchy—particularly in resource-limited settings—due to technical complexity, high costs, and lack of skilled personnel. Addressing these barriers through targeted capacity building and international funding is vital. Ongoing research should prioritize scalable, rapid, and cost-effective diagnostic platforms tailored for use in both high-income countries and LMICs.

ALTERNATIVES TO CONVENTIONAL ANTIBIOTICS ๐Ÿ’Š

With rising AMR, conventional antibiotics are losing efficacy, creating a pressing need for novel antimicrobial strategies in food systems. Promising alternatives include bacteriophage therapy, antimicrobial peptides (AMPs), plant-based antimicrobials, and CRISPR-Cas9 tools engineered to target resistance genes. These solutions, often highly specific and environmentally friendly, can reduce reliance on broad-spectrum antibiotics in agriculture and food preservation. This section discusses the current state of research into these alternatives, examining their effectiveness, regulatory hurdles, and scalability. While some therapies are in advanced clinical trials or experimental deployment, others face scientific and logistical constraints. Collaborative research must aim to optimize delivery systems, ensure safety, and streamline regulatory approval to enable wide-scale adoption of these promising tools in combating foodborne AMR.

POLICY, SURVEILLANCE, AND STEWARDSHIP FRAMEWORKS ๐Ÿ“Š

Global efforts to curb AMR in food safety depend heavily on the effectiveness of policy frameworks, surveillance systems, and antimicrobial stewardship programs (ASPs). Regulatory measures limiting antibiotic use in livestock, aquaculture, and food processing have shown success in reducing resistance rates in certain regions. However, gaps persist, especially in LMICs where regulations are poorly enforced and access to diagnostics remains limited. This section explores the evolution of international policies, such as the WHO Global Action Plan on AMR and Codex Alimentarius guidelines, and evaluates national-level implementation. Surveillance data must be harmonized and shared across borders to enable timely interventions. ASPs must also be tailored to regional needs, involving stakeholders from farming to retail. Continued research is needed to assess the effectiveness of these interventions and propose adaptive, equity-driven strategies that promote sustainable food safety practices worldwide.


๐ŸŒ Visit: https://infectious-diseases-conferences.pencis.com
๐Ÿ† Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee
๐Ÿ“ Registration: https://infectious-diseases-conferences.pencis.com/award-registration/
๐Ÿ“ง Contact: infectioussupport@pencis.com

Hastags

#AMR #FoodSafety #OneHealth #AntimicrobialResistance #PathogenControl #MicrobialHazards #ResistantBacteria #GlobalHealthThreat #Salmonella #Ecoli #Listeria #Campylobacter #Metagenomics #CRISPR #NextGenTherapeutics #BacteriophageTherapy #SurveillanceSystems #StewardshipPrograms #PublicHealthPolicy #FoodborneDiseases

Saturday, July 5, 2025

Extracellular N-Glycosylated Fn3 in E. coli | Signal Peptide Optimization ๐Ÿš€ #BiotechInnovation #pencis



INTRODUCTION

Fn3 3.4.4, a rationally engineered variant of the fibronectin type III (Fn3) domain, plays a pivotal role in extracellular matrix interactions and tumorigenesis regulation. Due to its potential biomedical and therapeutic relevance—especially in cancer-targeting applications—efficient extracellular production of both glycosylated and aglycosylated forms is essential. However, the challenge of secreting functional Fn3 proteins outside the cytoplasmic environment in Escherichia coli has historically hindered scalable production. This study presents a refined strategy that combines genetic engineering, strain selection, and chemical facilitation to achieve high-efficiency extracellular secretion. By utilizing specific signal peptides (SPs) such as OmpA, PelB, and L-AsPsII, along with recombinant expression in strains like E. coli BL21 (DE3) and DKK601, researchers successfully enhanced secretion. The use of Triton X-100 further boosted protein excretion, highlighting its utility as a mild surfactant in extracellular expression systems. Most notably, N-glycosylated Fn3 3.4.4 retained its functionality, binding effectively to mesothelin (MSLN) as verified by ELISA. This work not only advances understanding of extracellular protein production but also supports industrial-scale development of therapeutic proteins.

ENGINEERED SIGNAL PEPTIDES FOR EFFICIENT EXCRETION

Signal peptides (SPs) are critical determinants of successful protein localization and secretion in bacterial systems. In this study, three SPs—OmpA, PelB, and L-AsPsII—were employed to direct the transport of Fn3 3.4.4 to the periplasm or extracellular medium. Among these, PelB was particularly efficient in delivering the protein to the periplasm due to its superior cleavage rate, allowing the accumulation of soluble, correctly folded Fn3. Conversely, OmpA showed promise in directing N-glycosylated Fn3 3.4.4 out into the culture medium, highlighting its potential for extracellular expression. The strategic comparison of SP performance demonstrated that proper selection and pairing of SPs with target proteins is crucial for maximizing expression and downstream recovery. This insight is valuable for optimizing secretion of other glycoproteins in bacterial platforms.

N-GLYCOSYLATION AND FUNCTIONAL PROTEIN EXPRESSION

N-glycosylation is often essential for protein folding, stability, and bioactivity, yet it remains a complex task in E. coli due to its lack of native glycosylation pathways. This study leveraged engineered systems to express N-glycosylated Fn3 3.4.4 in E. coli, resulting in successful secretion into the culture medium, particularly under the guidance of the OmpA signal peptide. Importantly, the glycosylated protein maintained its affinity to mesothelin (MSLN), confirming structural integrity and biofunctionality. These findings reinforce that bacterial expression systems, when correctly tuned, can serve as viable hosts for glycoprotein production—a key advancement for recombinant therapeutics.

STRAIN SELECTION: BL21 (DE3) VS DKK601

Selecting the right bacterial host is pivotal for efficient recombinant protein expression. The study evaluated two commonly used strains: E. coli BL21 (DE3), known for high-level protein expression, and DKK601, an engineered strain optimized for glycosylation compatibility. While BL21 (DE3) showed robust performance in expressing aglycosylated Fn3 3.4.4, DKK601 demonstrated superiority in supporting N-glycosylation machinery. This differential performance underscores the importance of aligning host strain capabilities with the biochemical requirements of the target protein. It also highlights DKK601 as a promising chassis for future glycoengineering applications.

TRITON X-100 ENHANCES EXTRACELLULAR PROTEIN RELEASE

Chemical additives like Triton X-100 can significantly influence protein excretion without compromising cellular viability. In this study, low concentrations of Triton X-100 were used post-induction to facilitate the release of Fn3 3.4.4, particularly the N-glycosylated form, into the culture medium. Acting as a mild non-ionic surfactant, Triton X-100 likely disrupted membrane tension, enhancing leakage or secretion pathways. This approach presents a cost-effective, scalable solution for extracellular production and purification, particularly when paired with optimal signal peptides and host strains. These findings pave the way for simplified downstream processing in protein manufacturing pipelines.

APPLICATIONS IN BIOTHERAPEUTIC DEVELOPMENT

The demonstrated extracellular expression and functional validation of N-glycosylated Fn3 3.4.4 open promising avenues in therapeutic development. Fn3 domains are widely explored for their small size, stability, and targeting potential—especially in cancer therapies involving antigens like mesothelin. The ability to produce functional glycosylated Fn3 variants in E. coli enables faster, more economical production compared to eukaryotic systems. Moreover, this scalable platform can be extended to engineer and produce other glycoprotein-based biotherapeutics, making it a valuable tool for biotechnology, diagnostics, and personalized medicine.


๐Ÿ“Œ Visit: https://infectious-diseases-conferences.pencis.com
๐Ÿ… Nominate Now: https://infectious-diseases-conferences.pencis.com/award-nomination/?ecategory=Awards&rcategory=Awardee
๐Ÿ“ Register: https://infectious-diseases-conferences.pencis.com/award-registration/
๐Ÿ“ง Contact Us: infectioussupport@pencis.com


 Hashtags

#Fn3Protein, #NGlycosylation, #EcoliExpression, #SignalPeptide, #ProteinSecretion, #PelB, #OmpA, #LAsPsII, #BL21DE3, #DKK601, #TritonX100, #RecombinantProtein, #ProteinEngineering, #ExtracellularSecretion, #FibronectinDomain, #MesothelinBinding, #ELISAValidation, #Biopharmaceuticals, #CancerTargeting, #PencisConferences,

"COVID-19 Impact on Seasonal Outbreak Detection: SARIMAX-LSTM Hybrid Model Explained #InfectiousDiseases #COVID19Research #Pencis"

INTRODUCTION Seasonal infectious diseases have long posed significant public health challenges in the Republic of Korea. Influenza, noroviru...